⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BMY

Bristol-Myers Squibb Company

Healthcare · Drug Manufacturers - General

64.41USD

-0.2800 (-0.43%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 64.41
P/E14.2
Dvd Ind Yld3.9%
P/B5.90
P/S2.7
Curr EV/T12M EBITDA8.7
Mkt Cap (USD)131.6B
Curr EV (USD)165.6B
2)

Per Share Data

EPS T12M4.54
DPS2.49
Bk Val Per Sh10.93
Rev/Sh24.02
Cash/Sh5.42
Curr Shares Out2,042.7M
FCF/Sh5.59
3)

Cash Flow Analysis

P/CF10.3
Curr P/FCF11.5
CF/NI1.4
Dvd P/O54.9%
Cash Gen/Cash Reqd2.0
Csh Dvd Cov2.5
CFO/Sales26.0%
Eff Interest Rate3.7%
4)

Growth Potential

Dil EPS 1Y Gr178.5%
Cap 1Y Gr-3.6%
BPS 1Y Gr12.4%
R&D To Sales21.8%
Retention Rate45.1%
Rev 1Y Gr-0.2%
FCF 1Y Gr-7.9%
Assets 1Y Gr-2.8%
5)

Profitability

EBITDA18.9B
EBIT—
Operating Margin34.4%
Pretax Margin24.2%
Net Margin18.9%
ROA10.2%
ROE46.7%
ROC—
Asset Turnover0.54
6)

Structure

Current Ratio1.53
Quick Ratio1.29
Debt/Assets49.2%
Debt/Com Eq193.2%
Net Debt/EBITDA1.82
Tot Debt/Capital65.9%
Gross Margin70.2%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.